Definium Therapeutics, Inc. Operating Lease Right-of-Use Assets
Definium Therapeutics, Inc. (DFTX) had Operating Lease Right-of-Use Assets of $600.00 thousand as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-07-31
- 2025-06-30: Operating Lease, Right-of-Use Asset $600.00K.
- 2022-04-30: Operating Lease, Right-of-Use Asset $200.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-06-30 | $600.00K 10-Q · filed 2025-07-31 |
| 2022-04-30 | $200.00K 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |